Timeline

Voting rights breakdown

Notice details

Beneficial owner

Kuros Biosciences AG

Conditional Obligation to issue new shares pursuant to a Combination Agreement entered with shareholders of Xpand Biotechnology BV on 18 December 2016: 1'365'000 shares of Kuros Biosciences Ltd have been issued and transferred at closing of the Combination Agreement and 370'000 shares of Kuros Biosciences Ltd have been issued and transferred after achievement of the first product milestone in September 2017. The remaining 370'000 shares of Kuros Biosciences Ltd to be issued at the achievement of certain product approval milestones.